Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q3 2026, worth $682.2K in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Tempest Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q2 2026
- Shares held
- 818.7K
- −475.6K (−36.7%) vs. Q2 2026
- Total value
- $682.2K
- −$754.4K (−52.5%) vs. Q2 2026
- New holders
- 8
- 2 more added
- Sold out
- 5
- 3 more reduced
1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 23 | $682.2K |
| Q2 2026 | 21 | $1.44M |
| Q1 2026 | 22 | $1.29M |
| Q4 2025 | 21 | $2.26M |
| Q3 2025 | 17 | $6.02M |
| Q2 2025 | 18 | $6.42M |
| Q1 2025 | 24 | $4.42M |
| Q4 2024 | 35 | $5.66M |
| Q3 2024 | 28 | $3.94M |
| Q2 2024 | 24 | $4.70M |
| Q1 2024 | 30 | $7.29M |
| Q4 2023 | 32 | $9.74M |
| Q3 2023 | 24 | $1.05M |
| Q2 2023 | 22 | $4.86M |
| Q1 2023 | 17 | $7.21M |
| Q4 2022 | 13 | $3.54M |
| Q3 2022 | 16 | $5.36M |
| Q2 2022 | 16 | $6.67M |
| Q1 2022 | 15 | $7.12M |
| Q4 2021 | 19 | $12.4M |
| Q3 2021 | 22 | $31.8M |
| Q2 2021 | 24 | $20.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Versant Venture Management, LLC | 269,772 | $225.1K | 0.21% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 233,888 | $195.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 74,076 | $61.8K | 0.00% | −12,549−14.5% | Reduced |
| Vanguard Fiduciary Trust Co | 68,908 | $57.5K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 39,068 | $32.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25,170 | $21.0K | 0.00% | +19,534+346.6% | Added |
| HRT Financial LP | 21,315 | $17.0K | 0.00% | +21,315 | New |
| Northern Trust Corp | 20,136 | $16.8K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 15,426 | $12.9K | 0.00% | +15,426 | New |
| StoneX Group Inc. | 13,668 | $11.7K | 0.00% | +13,668 | New |
| JustInvest LLC | 11,672 | $9.74K | 0.00% | +11,672 | New |
| TRB Wealth Management, LLC | 10,846 | $9.05K | 0.00% | +10,846 | New |
| Nuveen, LLC | 5,958 | $4.83K | 0.00% | +5,958 | New |
| Tower Research Capital LLC (TRC) | 4,846 | $4.04K | 0.00% | +924+23.6% | Added |
| Morgan Stanley | 2,022 | $1.69K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,439 | $1.16K | 0.00% | −74−4.9% | Reduced |
| Federation des caisses Desjardins du Quebec | 292 | $244 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 134 | $112 | 0.00% | +134 | New |
| SBI Securities Co., Ltd. | 56 | $47 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 18 | $15 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 15 | $13 | 0.00% | +15 | New |
| BNP Paribas Arbitrage, SA | 3 | $2 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | −2−66.7% | Reduced |
| Sabby Management, LLC | 0 | $0 | 0.00% | −511,286−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −30,900−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,820−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −239−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −222−100.0% | Sold out |
| Royal Bank of Canada | – | – | – | – | Not filed |